ClinConnect ClinConnect Logo
Search / Trial NCT06788795

Effectiveness of a Wearable Hydration Device

Launched by METROHEALTH MEDICAL CENTER · Jan 16, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Dehydration Total Body Water Bioimpedence Emergency Department

ClinConnect Summary

This clinical trial is studying a new wearable device designed to help monitor hydration levels in older adults. Dehydration can cause serious health issues, especially in people over 55, and this trial aims to see if the device can accurately measure how hydrated someone is at home and encourage them to drink more fluids. By using this device, the researchers hope to find out if continuous feedback about hydration can lead to better health outcomes and fewer emergency department visits for dehydration-related problems.

To participate, individuals must be 55 years or older, have visited the emergency department with suspected dehydration, and be able to speak English. Participants will wear the device, keep track of how much they drink at home, and return for a check-up after about a week. This trial is important because it could lead to a better understanding of how to manage hydration in older adults and help with the development of this wearable technology for future use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients aged 55 and over
  • rresenting to the emergency department
  • clinical suspicion of dehydration
  • treatment of dehydration/syncope with fluid resuscitation
  • English speaking
  • Exclusion Criteria:
  • Refusal or inability to give informed consent,
  • severe clinical symptom requiring escalation of care beyond fluid resuscitation (ex. vasopressors, invasive blood pressure monitoring)
  • presumed/confirmed diagnosis of syncope secondary to a non-dehydration cause (ex. arrhythmia, stroke, pulmonary embolism, sepsis, valvular heart disease)
  • inability to lay flat for the test
  • body weight greater than 350 lbs
  • inability to fit measurement devices around the participant wrist
  • abnormal bodily fluid retention (lymphedema, ascites, pleural effusions, peripheral edema)
  • neuromotor disorders
  • current congestive heart failure exacerbation or heart attack/myocardial infarction
  • any implantable electronic devices
  • skin on limbs in poor condition (excessively, dry or rough or abrasions or wounds that would preclude application of electrode adhesive)

About Metrohealth Medical Center

MetroHealth Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, MetroHealth collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. With a commitment to ethical research practices and participant safety, the center leverages its extensive resources and expertise to contribute to the scientific community and enhance healthcare outcomes. Through rigorous clinical trials, MetroHealth aims to translate research findings into tangible benefits for patients, fostering a culture of excellence in clinical research.

Locations

Patients applied

0 patients applied

Trial Officials

Jospeh S Piktel, MD

Principal Investigator

MetroHealth System, Ohio

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported